ADVERTISEMENT
Subscribe | Advertise | FAQ
Search
Nursing Jobs
Search CE by Category
CE Courses
Advanced Practice (353)
Ambulatory Care (220)
Bio/Radiological Terrorism (10)
Bioethics (17)
Cardiology (57)
Case Management (46)
CCMC Preapproved (34)
CMS Hospital-Acquired Conditions (32)
Complementary Healthcare/Wellness (34)
Correctional Health (35)
Critical Care (139)
Cultural Competency (24)
Diabetes (14)
Emergency (150)
Endocrinology (13)
ENT (12)
FL State Required (3)
Forensic (7)
Future of Nursing (26)
Gastroenterology (20)
Gerontologic (63)
Home Health (141)
Immunology (21)
Infectious Disease/Control (62)
Informatics (6)
Interprofessional CE (170)
Joint Commission Related (31)
KY State Required (2)
Legal and Regulatory (46)
LPN (Licensed Practical Nurse) (14)
Magnet Related (104)
Management and Leadership (99)
Medical/Surgical (298)
Men's Health (25)
MI State Required (1)
Neonatal (14)
Neurology (37)
NJ State Required (1)
Nursing Assistants (5)
Nursing Re-Entry (66)
Nutrition (52)
NV State Required (1)
NY State Required (2)
OH State Required (1)
Oncology (81)
Ophthalmology (5)
OR State Required (1)
Orthopedic (23)
Pain Management (15)
Pediatric (83)
Perinatal (56)
Perioperative (52)
Professional Development (98)
Psychiatric (61)
Public Health (94)
Puerto Rico Required (1)
Pulmonary (21)
Rehabilitation (70)
School Nursing (61)
Spanish (6)
Stroke/Primary Stroke Center (34)
Webinar (103)
Women's Health (102)
CE by Type
CE Resources
Cancer Treatment - CE342-60
Cancer Treatment
Role of Monoclonal Antibodies
by Sherri Konzem Boehringer, PharmD, BCPS and Carol S. Blecher, RN, MS, AOCN, APN, C and Julie Eggert, PhD, APRN-BC GNP, AOCN and Jennifer Stephens, RN, MN, OCN, AOCN
CE342-60 l 1.00 contact hrs

Price: $ 10.00
Free for Unlimited CE Subscribers

Average Rating
 (4.3 / 3872 reviews)

CE OVERVIEW REVIEWS     
Objectives:
The purpose of this monoclonal antibodies CE module is to educate nurses about monoclonal antibodies and their role in cancer treatment. After studying the information presented here, you will be able to:
  • Explain the development of monoclonal antibodies (MAb)
  • Differentiate between a conjugated and unconjugated MAb
  • Discuss indications, adverse effects and response rates for designated MAb

This course will be updated or discontinued on or before 3/1/2015

Recommended CE
 
Bladder Cancer
Nurses Need to Know Risk Factors, Treatment Option
The purpose of this bladder cancer CE program is to provide nurses with an overview of bladder cancer, includi... More Info
Common Fallacies About Cancer Pain
The goal of this continuing education program is to clarify healthcare professionals’ understanding of c... More Info
Cancer Update

The goal of this continuing education program is to update nurses’, dietitians’, health educa... More Info
How To Stay Safe While Administering Chemotherapy
The goal of this chemotherapy administration continuing education program is to provide nurses with informatio... More Info

Gannett Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation

Accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with this activity. Unless stated above, the planners and authors of this course have declared no real or perceived conflicts of interest that relate to this educational activity. Gannett Education guarantees this educational activity is free from bias.

Please see CE Course Instructions to learn how to earn CE credit for this module.

This course completion will be electronically reported to CE Broker as required per Florida Statute 456.025(7). Click here to view your CE Broker transcript and check the status of your CE requirements with a FREE 7-day CE Broker trial subscription. It may take up to 24 hours for the course to appear on your CE Broker transcript.